![]() |
|
|
Vol. 288, Issue 1, 295-301, January 1999
- and
-Adrenoceptor Blockade on Purine Secretion
Induced by Sympathetic Nerve Stimulation in the Rat
Kidney1
Center for Clinical Pharmacology, Departments of Pharmacology and
Medicine, University of Pittsburgh Medical Center, Pittsburgh,
Pennsylvania
To characterize the effects of renal sympathetic nerve activation
(RSNA) on renal purine secretion, 13 perfused rat kidneys were
stimulated with periarterial electrodes at 7 Hz for 3 min, and purine
secretion was determined by measuring with high-performance liquid
chromatography purines in the renal venous perfusate 1 min before and
during the last minute of RSNA. RSNA significantly increased renal
perfusion pressure and significantly increased the secretion of
adenosine and adenosine metabolites (inosine, hypoxanthine, and
xanthine) by 2- to 5-fold. To investigate the participation of
- and
-adrenoceptors in this response, four groups of perfused kidneys
(n = 5/group) were pretreated with either vehicle,
prazosin (
1-adrenoceptor antagonist; 0.03 µM), phentolamine (
1/2-adrenoceptor antagonist; 3 µM), or
propranolol (
1/2-adrenoceptor antagonist; 0.1 µM), and
purine secretion was measured before and during RSNA at 1, 3, 5, 7, and
9 Hz. Prazosin, phentolamine, and propranolol abolished the
RSNA-induced increase in the secretion of adenosine, inosine,
hypoxanthine, and xanthine. In contrast, prazosin and phentolamine
nearly abolished, whereas propranolol only slightly reduced, renal
vascular responses to RSNA. Our results indicate that RSNA increases
renal purine secretion via a mechanism that requires both
- and
-adrenoceptors. It is well known that in the kidney adenosine
activates renal afferent nerves, enhances renovascular responses to
norepinephrine and angiotensin II, and increases sodium reabsorption;
therefore, RSNA-induced adenosine production may contribute to the
hypertensive effects of RSNA. Moreover, the antihypertensive
effects of
-adrenoceptor antagonists may in part be due to
inhibition of RSNA-induced renal adenosine production.
This article has been cited by other articles:
![]() |
J. Ren, Z. Mi, and E. K. Jackson Assessment of Nerve Stimulation-Induced Release of Purines from Mouse Kidneys by Tandem Mass Spectrometry J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 920 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. TAKEZAKO, K. NODA, E. TSUJI, M. KOGA, M. SASAGURI, and K. ARAKAWA Adenosine Activates Aromatic L-Amino Acid Decarboxylase Activity in the Kidney and Increases Dopamine J. Am. Soc. Nephrol., January 1, 2001; 12(1): 29 - 36. [Abstract] [Full Text] |
||||
![]() |
E. K. Jackson and Z. Mi Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28. [Abstract] [Full Text] |
||||